Therefore, sMEK1 and paclitaxel inhibited the growth of ovarian carcinoma cells by inducing apoptotic death via the Akt-Rheb/mTORC1-S6K/4E-BP-dependent signaling pathways. Here, PPP4R3A is linked to ovarian carcinoma.